Trupanion (NASDAQ:TRUP) Receives "Hold (C-)" Rating from Weiss Ratings

Key Points

• Trupanion has received a "hold (C-)" rating from Weiss Ratings, with analysts highlighting mixed sentiments as two analysts have a Buy rating while four maintain a Hold rating.
• The company's recent quarterly earnings report revealed a net income of $0.22 per share, exceeding analysts' expectations, alongside a revenue increase of 12.3% year-over-year.
• Significant insider trades were noted, with CEO Margaret Tooth and Director Darryl Rawlings both selling shares, indicating a 5.85% and 2.10% decrease in their stakes, respectively.

Trupanion (NASDAQ:TRUP - Get Free Report)'s stock had its "hold (c-)" rating reiterated by equities research analysts at Weiss Ratings in a research report issued on Friday,Weiss Ratings reports.

A number of other research analysts have also weighed in on TRUP. Piper Sandler increased their price target on Trupanion from $62.00 to $67.00 and gave the stock an "overweight" rating in a research note on Friday, August 8th. Cantor Fitzgerald raised Trupanion to a "hold" rating in a research report on Wednesday, August 13th. Finally, Stifel Nicolaus increased their target price on Trupanion from $41.00 to $45.00 and gave the stock a "hold" rating in a research report on Friday, August 8th. Two analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat.com, Trupanion presently has a consensus rating of "Hold" and an average target price of $53.80.

Trupanion Trading Down 0.1%

Shares of Trupanion stock traded down $0.04 during trading hours on Friday, reaching $43.80. 328,362 shares of the company's stock were exchanged, compared to its average volume of 362,629. Trupanion has a 52-week low of $31.00 and a 52-week high of $57.90. The firm has a market capitalization of $1.88 billion, a price-to-earnings ratio of 168.47 and a beta of 1.83. The company has a fifty day moving average of $44.21 and a 200-day moving average of $45.86. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.32.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The financial services provider reported $0.22 earnings per share for the quarter, topping analysts' consensus estimates of ($0.03) by $0.25. Trupanion had a return on equity of 3.31% and a net margin of 0.81%.The company had revenue of $353.56 million for the quarter, compared to analyst estimates of $346.73 million. During the same quarter in the prior year, the company posted ($0.14) EPS. The business's revenue for the quarter was up 12.3% compared to the same quarter last year. Trupanion has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Sell-side analysts forecast that Trupanion will post 0.13 EPS for the current fiscal year.

Insider Activity at Trupanion

In related news, CEO Margaret Tooth sold 8,961 shares of the stock in a transaction on Thursday, September 25th. The stock was sold at an average price of $41.88, for a total value of $375,286.68. Following the completion of the sale, the chief executive officer directly owned 144,229 shares in the company, valued at approximately $6,040,310.52. This represents a 5.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Darryl Rawlings sold 30,369 shares of the stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $44.70, for a total value of $1,357,494.30. Following the completion of the sale, the director owned 1,413,281 shares of the company's stock, valued at approximately $63,173,660.70. This represents a 2.10% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 61,761 shares of company stock worth $2,739,621. Corporate insiders own 5.42% of the company's stock.

Institutional Trading of Trupanion

Several large investors have recently added to or reduced their stakes in the stock. Hosking Partners LLP increased its holdings in Trupanion by 4.9% in the 3rd quarter. Hosking Partners LLP now owns 430,930 shares of the financial services provider's stock valued at $18,651,000 after purchasing an additional 20,260 shares in the last quarter. SG Americas Securities LLC increased its holdings in Trupanion by 216.8% in the 3rd quarter. SG Americas Securities LLC now owns 20,068 shares of the financial services provider's stock valued at $869,000 after purchasing an additional 13,733 shares in the last quarter. Inspire Investing LLC grew its stake in shares of Trupanion by 49.2% during the third quarter. Inspire Investing LLC now owns 10,487 shares of the financial services provider's stock valued at $454,000 after acquiring an additional 3,456 shares in the last quarter. Kopion Asset Management LLC grew its stake in shares of Trupanion by 20.8% during the third quarter. Kopion Asset Management LLC now owns 264,603 shares of the financial services provider's stock valued at $11,452,000 after acquiring an additional 45,594 shares in the last quarter. Finally, AdvisorNet Financial Inc grew its stake in shares of Trupanion by 2.5% during the third quarter. AdvisorNet Financial Inc now owns 14,210 shares of the financial services provider's stock valued at $615,000 after acquiring an additional 350 shares in the last quarter.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.